Corify Care Partners with Mayo Clinic for AI-Enhanced Cardiac Arrhythmia Care

Corify Care has announced a collaboration with Mayo Clinic to improve cardiac arrhythmia care through AI technology, announced in a press release. This partnership aims to refine Corify's global cardiac mapping technology, which provides real-time precision guidance for arrhythmia treatment.

The collaboration will involve select Mayo Clinic physicians who will assist Corify in enhancing the usability and clinical flow of its current model. Corify's technology offers a noninvasive approach to cardiac mapping, creating detailed three-dimensional maps of the heart's electrical activity. This method aims to improve the accuracy of arrhythmia diagnosis and management, potentially reducing the risk of recurrence.

Corify's system has already been recognized across Europe for its clinical impact, having been used in approximately 2,000 cases. The company is pursuing FDA approval following its CE Mark certification in 2024 under the European Union's Medical Device Regulation.